Treatment of headache with botulinum toxin A - A review according to evidence-based medicine criteria

Cephalalgia

Volumn 22, Issue 9, 2002, Pages 699-710

  Evers, Stefan ^a   Rahmann, A ^a   Vollmer Haase, J ^a   Husstedt, I W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Botulinum toxin A; Evidence based medicine; Idiopathic headache; Migraine; Tension type headache

Indexed keywords

BOTULINUM TOXIN A; LIDOCAINE; METHYLPREDNISOLONE;

CLINICAL TRIAL; CLUSTER HEADACHE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HEADACHE; HUMAN; METHODOLOGY; MIGRAINE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; ANIMAL; PATHOPHYSIOLOGY;

ANIMALS; BOTULINUM TOXIN TYPE A; EVIDENCE-BASED MEDICINE; HEADACHE; HUMANS;

EID: 0036834143     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2002.00390.x     Document Type: Review

References (45)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl. 7):1-92.
2. Perfetto EM, Morris LS. Agency for Health Care Policy and Research clinical practice guidelines. Ann Pharmacother 1996; 30:1117-21.
3. Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Botulinumtoxin A in der Therapie idiopathischer Kopfschmerzerkrankungen - bisherige Studien und Evidenzklassifizierung. Nervenheilkunde 2001; 20:573-9.
4. Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001; 41:658-64.
5. Burch CM, Kokoska MS, Glaser DA, Hollenbeak CS. Treatment of frontal tension headaches with botulinum toxin A. Cephalalgia 2001; 21:486-91.
6. Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin A: a double-blind, placebo-controlled study. Headache 2000; 40:300-5.
7. Smuts JA, Baker MK, Smuts HM, Stassen JMR, Roussouw E, Barnard PWA. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999; 6 (Suppl. 4):99-102.
8. Relja MA, Klepac N. Botulinum toxin A as prophylactic treatment in chronic tension-type headache: long-term follow-up study. Neurology 2001; 56 (Suppl. 3):A349-50.
9. Schoenen J. Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials. Cephalalgia 1995; 15:165-79.
10. Göbel H, Lindner V, Krack P, Heinze A, Gaartz N, Deuschl G. Treatment of chronic tension-type headache with botulinum toxin. Cephalalgia 1999; 19:455.
11. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache. Curr Rev Pain 2000; 4:31-35.
12. Klapper JA, Mathew NT, Klapper A, Kailasam J. Botulinum toxin type A (BTX-A) for the prophylaxis of chronic daily headache. Cephalalgia 2000; 20:292-3.
13. Robbins L. Botulinum toxin A for refractory chronic daily headache. Neurology 2001; 56 (Suppl. 3):A349.
14. Relja M. Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol 1997; 4 (Suppl. 2):71-73.
15. Relja M. Treatment of tension-type headache with botulinum toxin: 1-year follow-up. Cephalalgia 2000; 20:336.
16. Mauskop A. Botulinum toxin in the treatment of chronic daily headaches. Cephalalgia 1999; 19:453.
17. Zwart JA, Bovim G, Sand T, Sjaastad O. Tension headache: botulinum toxin paralysis of temporal muscles. Headache 1994; 34:458-62.
18. Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur J Med Res 1999; 4:183-6.
19. Smuts JA, Barnard PWA. Botulinum toxin type A in the treatment of headache syndromes: a clinical report on 79 patients. Cephalalgia 2000; 20:332-7.
20. Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998; 38:468-71.
21. Rollnik JD, Karst M, Fink M, Dengler R. Botulinum toxin type A and EMG: a key to the understanding of chronic tension-type headaches? Headache 2002; 41:985-9.
22. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. Headache 2000; 40:445-50.
23. Brin MF, Swope DM, O'Brian C, Abbasi S, Pogoda JM. Botox® for migraine: double-blind, placebo-controlled, region-specific evaluation. Cephalalgia 2000; 20:421-2.
24. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 2000; 123:669-76.
25. Mauskop A, Basdeo R. Botulinum toxin A is an effective prophylactic therapy for migraines. Cephalalgia 2000; 20:422.
26. Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache 2000; 40:231-6.
27. Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. Headache 1998; 38:442-5.
28. Schnider P, Moraru E, Bittner C, Vigl M, Wöber C, Maly J et al. Physical therapy and botulinum toxin type A in patients with cervical associated headache according to HIS criteria: double-blind placebo-controlled study. Neurology 2001; 56 (Suppl. 3):A349.
29. Hobson DE, Gladish DF. Botulinum toxin injection for cervicogenic headache. Headache 1997; 37:253-5.
30. Robbins L. Botulinum toxin A (Botox) for cluster headache: 6 cases. Cephalalgia 2000; 21:499-500.
31. Freund BJ, Schwartz M. The use of botulinum toxin-A in the treatment of refractory cluster headache: case reports. Cephalalgia 2000; 20:329-30.
32. Göbel H, Heinze A, Heinze-Kuhn K. Botulinum toxin A in the treatment of chronic paroxysmal hemicrania - a case report. Cephalalgia 2001; 21:506.
33. Guyer BM. Mechanism of Botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999; 3:427-31.
34. Göbel H, Heinze A, Heinze-Kuhn K, Austermann K. Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 2001; 91:195-9.
35. Ceballos-Baumann AO, Petri S, Toelle T, Heckmann M, Conrad B. Neues in der Botulinumtoxin-Therapie - Von der Dystonie bis zur Migräneprophylaxe. Nervenheilkunde 2001; 20:151-7.
36. Pacchetti C, Albani G, Martignoni E, Godi L, Alfonsi E, Nappi G. 'Off' painful dystonia in Parkinson's disease treated with botulinum toxin. Mov Disord 1995; 10:333-6.
37. Wissel J, Müller J, Dressnandt J, Heinen F, Naumann M, Topka H et al. Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage 2000; 20:44-49.
38. Barwood S, Baillieu C, Boyd R, Brereton K, Low J, Nattrass G et al. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol 2000; 42:116-21.
39. Svensson P, Jensen K. Human studies of experimental pain from muscles. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. Philadelphia: Lippincott, 2000:565-72.
40. Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993; 113:400-4.
41. Rosales RL, Arimura K, Ikenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection. Muscle Nerve 1996; 19:488-96.
42. 125I-labelled botulinum A neurotoxin: pharmacokinetics on cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1977; 298:235-8.
43. Verderio C, Coco S, Rossetto O, Montenucco C, Matteoli M. Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes. J Neurochem 1999; 73:372-9.
44. Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000; 38:245-58.
45. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993; 33:48-56.